Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 101 - 110 of 196 Results.

A Three-Item Post-Pandemic Regulatory Wishlist
Art Carden | Commentary | Aug. 20, 2020
Economic Freedom Hastens Pandemic Recovery
Art Carden | Commentary | Aug. 15, 2020
Why Has the FDA Not Approved Home-Based Coronavirus Testing?
John C. Goodman | Commentary | Aug. 15, 2020
How to Get a COVID-19 Vaccine Faster
Raymond J. March | Commentary | July 21, 2020
The Five Deadly Sins of Private Health Insurance
John C. Goodman | Commentary | June 2, 2020
Challenging Anthony Fauci
K. Lloyd Billingsley | Commentary | May 16, 2020
Key to COVID-19 Recovery: Deregulation
John C. Goodman | Commentary | May 4, 2020
Anthony Fauci: A Product of His Training
Ronald L. Trowbridge | Commentary | Apr. 27, 2020
Coronavirus: The Great Deregulator
Adam B. Summers | Commentary | Apr. 27, 2020
Trump and Right to Try
Ronald L. Trowbridge | Commentary | Apr. 16, 2020






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL